20|20 OptimEyes Technologies Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
2ndary - Private
- Investors
-
8
20|20 OptimEyes Technologies General Information
Description
Developer of a mucoadhesive drug delivery platform designed to improve treatments for patients with vision loss and other ocular conditions. The company focuses on developing mucosal drug delivery systems with an initial emphasis on eye-drop formulations for glaucoma and dry eye diseases, enabling clients to access effective and targeted treatment options.
Contact Information
Website
www.2020optimeyes.caCorporate Office
- 175 Longwood Road South
- Suite 301A
- Hamilton, Ontario L8P 0A1
- Canada
Corporate Office
- 175 Longwood Road South
- Suite 301A
- Hamilton, Ontario L8P 0A1
- Canada
20|20 OptimEyes Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Secondary Transaction - Private | 01-Jun-2026 | Completed | Generating Revenue | |||
| 12. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 11. Accelerator/Incubator | 31-Mar-2026 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 25-Nov-2025 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | 23-Sep-2025 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 7. Seed Round | 11-Nov-2022 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 5. Grant | 04-Apr-2017 | $2.5K | Completed | Generating Revenue | ||
| 4. Grant | 24-Mar-2017 | $30K | Completed | Generating Revenue |
20|20 OptimEyes Technologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
20|20 OptimEyes Technologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
20|20 OptimEyes Technologies Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Ontario Bioscience Innovation Organization | Not-For-Profit Venture Capital | |||
| Capital BioVentures | Accelerator/Incubator | |||
| University of Toronto | University | |||
| FACIT | Venture Capital | Minority | ||
| Creative Destruction Lab | Accelerator/Incubator |
20|20 OptimEyes Technologies FAQs
-
When was 20|20 OptimEyes Technologies founded?
20|20 OptimEyes Technologies was founded in 2015.
-
Where is 20|20 OptimEyes Technologies headquartered?
20|20 OptimEyes Technologies is headquartered in Hamilton, Canada.
-
What is the size of 20|20 OptimEyes Technologies?
20|20 OptimEyes Technologies has 4 total employees.
-
What industry is 20|20 OptimEyes Technologies in?
20|20 OptimEyes Technologies’s primary industry is Drug Delivery.
-
Is 20|20 OptimEyes Technologies a private or public company?
20|20 OptimEyes Technologies is a Private company.
-
What is 20|20 OptimEyes Technologies’s current revenue?
The current revenue for 20|20 OptimEyes Technologies is .
-
How much funding has 20|20 OptimEyes Technologies raised over time?
20|20 OptimEyes Technologies has raised $428K.
-
Who are 20|20 OptimEyes Technologies’s investors?
Ontario Bioscience Innovation Organization, Capital BioVentures, University of Toronto, FACIT, and Creative Destruction Lab are 5 of 8 investors who have invested in 20|20 OptimEyes Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
